Repsly Announces New Retail Technology Partnership with Curaleaf

1.4 min readPublished On: February 2nd, 2022By

BOSTON – Repsly, a retail technology platform, announced it has entered into a technology partnership agreement with Curaleaf (CSE: CURA / OTCQX: CURLF), an international provider of consumer products in cannabis. This agreement will support Curaleaf’s wholesale operations across the US by providing CRM solutions, retail execution support, and business analytics and insights to the Curaleaf teams.

With 125 dispensaries in 23 U.S. states, Curaleaf is one of the largest cannabis companies. Curaleaf chose Repsly after realizing a need to enhance their technology stack in support of their quickly expanding go-to-market needs within North America.

“With Repsly’s powerful operational platform and their Insights Dashboard business intelligence solution, we’ll be able to assess our wholesale execution plans with real-time and trended data on sales performance, promotion execution and more. These data-driven insights will allow our team to learn and pivot on a dime as feedback comes in from their field,” said Patrick Larkin, SVP of Sales at Curaleaf.

“Our team at Repsly is obsessed with helping our customers win by executing perfectly at all aspects of retail, every day,” said Matthew Brogie, CEO at Repsly. “Knowing that we have the opportunity to help Curaleaf navigate competitively in one of the fastest growing consumer industries, and that we can support Curaleaf and their portfolio of brands in their next generation plans is extremely energizing for our team! We’re looking forward to rolling up our sleeves and working hard to demonstrate that Repsly is the right partner to support Curaleaf in this amazing growth journey.”

Curaleaf will begin to roll out the Repsly platform in February 2022.

(This information is primarily sourced from Repsly Inc.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!